Hunan
300705.SZHunan Jiudian Pharmaceutical Co., Ltd. Price (300705.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
481,836,549
(251.2581)%Revenue and Profitability
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 241,413,229 | 266,489,389 | 290,492,436 | 376,400,199 | 534,515,072 | 801,375,318 | 924,061,197 | 978,159,132 | 1,627,664,942 | 2,326,215,867 | 2,692,511,460 |
| Net Income | 25,268,021 | 37,792,565 | 44,642,785 | 54,527,281 | 68,573,377 | 71,985,020 | 55,065,853 | 82,259,768 | 204,245,777 | 269,700,151 | 368,260,790 |
| FCF USD | -14,875,710 | 3,612,623 | 2,603,293 | 23,770,622 | -17,340,877 | -189,027,549 | -91,247,123 | 71,641,473 | 64,943,410 | -144,392,891 | 4,367,130 |
| OCF USD | 30,692,790 | 30,107,644 | 32,195,183 | 55,182,572 | 80,419,422 | 68,233,504 | 90,740,744 | 149,994,591 | 190,871,610 | 268,988,603 | 431,185,025 |
Financial Health - DEBT
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 | 1.25 | 0.86 | 1.10 | 0.86 | 0.90 |
| D/E | 0.17 | 0.07 | 0.08 | 0.06 | 0.01 | 0.11 | 0.18 | 0.11 | 0.30 | 0.20 | 0.19 |
| CA/CL | 1.98 | 2.57 | 2.92 | 3.25 | 6.49 | 2.97 | 2.26 | 2.78 | 2.75 | 2.72 | 3.44 |
| TA/TL | 3.30 | 4.57 | 4.99 | 5.39 | 7.06 | 4.19 | 3.46 | 3.83 | 2.70 | 3.08 | 3.20 |
| Total Debt | 30,000,000 | 15,000,000 | 20,000,000 | 20,000,000 | 4,000,000 | 79,689,441 | 140,157,231 | 88,423,138 | 328,578,252 | 316,440,581 | 384,375,602 |
Management Performance
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 10.07% | 15.44% | 14.84% | 15.35% | 9.61% | 8.70% | 6.24% | 8.65% | 14.27% | 14.05% | 14.40% |
| ROE | 14.36% | 18.01% | 17.54% | 16.86% | 10.39% | 10.02% | 7.23% | 9.84% | 18.58% | 17.37% | 18.66% |
| ROA | 0.00% | 14.07% | 14.02% | 13.73% | 8.91% | 7.63% | 5.14% | 7.27% | 11.70% | 11.73% | 12.83% |
| NM % | 10.47% | 14.18% | 15.37% | 14.49% | 12.83% | 8.98% | 5.96% | 8.41% | 12.55% | 11.59% | 13.68% |
| FCF / R% | 0.00% | 1.36% | 0.90% | 6.32% | -3.24% | -23.59% | -9.87% | 7.32% | 3.99% | -6.21% | 0.16% |
| FCF / NI% | -41.03% | 9.56% | 5.83% | 43.59% | -25.29% | -262.59% | -165.71% | 87.09% | 31.80% | -53.54% | 1.19% |
| Operating Margin (OM) | 0.00 | 0.41 | 0.10 | 0.17 | 0.24 | 0.22 | 0.23 | 0.29 | 0.28 | 0.27 | 0.33 |
Per Share
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.22 | 0.29 | 0.20 | 0.22 | 0.26 | 0.22 | 0.17 | 0.25 | 0.62 | 1.97 | 0.76 |
| SPS | 2.08 | 2.01 | 1.28 | 1.55 | 2.00 | 2.47 | 2.81 | 2.98 | 4.95 | 16.96 | 5.59 |
| OCPS | 0.26 | 0.23 | 0.14 | 0.23 | 0.30 | 0.21 | 0.28 | 0.46 | 0.58 | 1.96 | 0.89 |
| FCPS | -0.13 | 0.03 | 0.01 | 0.10 | -0.07 | -0.58 | -0.28 | 0.22 | 0.20 | -1.05 | 0.01 |
| BVPS | 1.52 | 1.59 | 1.12 | 1.33 | 2.48 | 2.21 | 2.32 | 2.54 | 3.35 | 11.32 | 4.10 |
Per Share - CAGR
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.22 | 0.29 | 0.20 | 0.22 | 0.26 | 0.22 | 0.17 | 0.25 | 0.62 | 1.97 | 0.76 |
| CAGR-SPS | 2.08 | 2.01 | 1.28 | 1.55 | 2.00 | 2.47 | 2.81 | 2.98 | 4.95 | 16.96 | 5.59 |
| CAGR-OCPS | 0.26 | 0.23 | 0.14 | 0.23 | 0.30 | 0.21 | 0.28 | 0.46 | 0.58 | 1.96 | 0.89 |
| CAGR-FCPS | -0.13 | 0.03 | 0.01 | 0.10 | -0.07 | -0.58 | -0.28 | 0.22 | 0.20 | -1.05 | 0.01 |
| CAGR-BVPS | 1.52 | 1.59 | 1.12 | 1.33 | 2.48 | 2.21 | 2.32 | 2.54 | 3.35 | 11.32 | 4.10 |